JESSICA ACOSTA: Open Payments
NPI 1942906722 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,680 in 215 payments from 49 companies in 2025. Trend: 2023 $1,300 · 2024 $3,765 · 2025 $5,680
Food & beverage: $5,012Education: $668
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 12 | $472 |
| Janssen Biotech, Inc. | 18 | $441 |
| SEAGEN INC. | 4 | $383 |
| PFIZER INC. | 20 | $352 |
| GlaxoSmithKline, LLC. | 14 | $301 |
| Genentech USA, Inc. | 10 | $288 |
| Novartis Pharmaceuticals Corporation | 16 | $286 |
| ABBVIE INC. | 11 | $282 |
| AstraZeneca Pharmaceuticals LP | 11 | $214 |
| GENZYME CORPORATION | 8 | $209 |
Products named: Enhertu, RYBREVANT, DATROWAY, KISQALI, Orserdu, JEMPERLI, Phesgo, REBLOZYL.
Industry payments across FL — which companies pay providers there.
